Adell Harriman & Carpenter’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Buy |
5,198
+23
| +0.4% | +$1.07K | 0.02% | 161 |
|
|
2025
Q1 | $316K | Hold |
5,175
| – | – | 0.02% | 148 |
|
|
2024
Q4 | $293K | Hold |
5,175
| – | – | 0.02% | 150 |
|
|
2024
Q3 | $268K | Sell |
5,175
-235
| -4% | -$12.2K | 0.02% | 151 |
|
|
2024
Q2 | $225K | Sell |
5,410
-458
| -8% | -$19K | 0.02% | 154 |
|
|
2024
Q1 | $318K | Sell |
5,868
-2
| -0% | -$108 | 0.03% | 144 |
|
|
2023
Q4 | $301K | Buy |
5,870
+625
| +12% | +$32.1K | 0.03% | 144 |
|
|
2023
Q3 | $304K | Sell |
5,245
-393
| -7% | -$22.8K | 0.03% | 144 |
|
|
2023
Q2 | $363K | Sell |
5,638
-82
| -1% | -$5.28K | 0.04% | 137 |
|
|
2023
Q1 | $396K | Buy |
+5,720
| New | +$396K | 0.04% | 134 |
|
|
2022
Q2 | – | Sell |
-2,840
| Closed | -$207K | – | 142 |
|
|
2022
Q1 | $207K | Buy |
+2,840
| New | +$207K | 0.02% | 168 |
|
|
2021
Q4 | – | Sell |
-4,424
| Closed | -$262K | – | 179 |
|
|
2021
Q3 | $262K | Buy |
4,424
+450
| +11% | +$26.6K | 0.03% | 163 |
|
|
2021
Q2 | $266K | Hold |
3,974
| – | – | 0.03% | 159 |
|
|
2021
Q1 | $251K | Sell |
3,974
-161
| -4% | -$10.2K | 0.03% | 149 |
|
|
2020
Q4 | $257K | Sell |
4,135
-120
| -3% | -$7.45K | 0.03% | 140 |
|
|
2020
Q3 | $257K | Sell |
4,255
-875
| -17% | -$52.8K | 0.04% | 135 |
|
|
2020
Q2 | $302K | Sell |
5,130
-300
| -6% | -$17.6K | 0.05% | 114 |
|
|
2020
Q1 | $303K | Sell |
5,430
-320
| -6% | -$17.8K | 0.06% | 112 |
|
|
2019
Q4 | $369K | Buy |
+5,750
| New | +$369K | 0.06% | 116 |
|